The patient working group is a brand new initiative within the NE&Y RTC.
Healthcare professionals and other NBTC stakeholders may wish to note an update from Jehovah’s Witnesses regarding individual decisions on the acceptance and donation of major blood components.
Following the February 2026 update to NICE QS138 Statement 2 on tranexamic acid (TXA), the QS138 Quality Insights quality improvement tool has been updated to reflect the broadened eligibility criteria.
National Transfusion Practitioners Network